Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders

Child and Adolescent Psychiatry and Mental Health

Volumn 4, Issue , 2010, Pages

  Langenbach, Tobias ^a   Spönlein, Alexandra ^b   Overfeld, Eva ^a   Wiltfang, Gaby ^a   Quecke, Niklas ^a   Scherbaum, Norbert ^a   Melchers, Peter ^b   Hebebrand, Johannes ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Kreiskrankenhaus Gummersbach   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONDUCT DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HOSPITALIZED ADOLESCENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA; SCHOOL DROPOUT; SEX DIFFERENCE; SOMATOFORM DISORDER; SUBSTANCE ABUSE;

EID: 77957117216     PISSN: None     EISSN: 17532000     Source Type: Journal    
DOI: 10.1186/1753-2000-4-25     Document Type: Article

References (46)

1. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national results on adolescent drug use: Overview of key findings, 2007 2008, Bethesda: National Institute on Drug Abuse.
2. Wittchen HU, Nelson CB, Lachner G. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol Med 1998, 28:109-126. 10.1017/S0033291797005928, 9483687.
3. Essau CA, Karpinski NA, Petermann F, Conradt J. Häufigkeit und Komorbidität psychischer Störungen bei Jugendlichen: Ergebnisse der Bremer Jugendstudie. Z Klin Psychol Psychiatr Psychother 1998, 46:105-124.
4. Brady KT, Malcom RJ. Substance use disorders and co-occuring axis I psychiatric disorders. The American Psychiatric Publishing Textbook of Substance Abuse Treatment 2004, 529-537. Washington: American Psychiatric Publishing, Galanter M, Kleber HD, 3.
5. Agosti V, Nunes E, Levin F. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse 2002, 28:643-652. 10.1081/ADA-120015873, 12492261.
6. Kandel DB, Johnson JG, Bird HR, Canino G, Goodman SH, Lahey BB, Regier DA, Schwab-Stone M. Psychiatric disorders associated with substance use among children and adolescents: Findings from the methods for the epidemiology of child and adolescent mental disorders (MECA) study. J Abnorm Child Psychol 1997, 25:121-132. 10.1023/A:1025779412167, 9109029.
7. Lieb R, Schuster P, Pfister H, Fuetsch M, Höfler M, Isensee B, Müller N, Sonntag H, Wittchen HU. Epidemiologie des Konsums, Missbrauchs und der Abhängigkeit von legalen und illegalen Drogen bei Jugendlichen und jungen Erwachsenen: Die prospektiv-longitudinale Verlaufsstudie EDSP. Sucht 2000, 46:18-31.
8. Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, Oppenkowski T, Stokes-Lampard H, Smith GD. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004, 363:1579-1588. 10.1016/S0140-6736(04)16200-4, 15145631.
9. Perkonigg A, Beloch E, Garzynski E, Nelson CB, Pfister H, Wittchen HU. Prävalenz von Drogenmissbrauch und -abhängigkeit bei Jugendlichen und Erwachsenen: Gebrauch, Diagnosen und Auftreten erster Missbrauchs- und Abhängigkeitsmerkmale. Z Klin Psychol Psychother 1997, 26:247-257.
10. Wittchen HU, Perkonigg A, Reed V. Comorbidity of mental disorders and substance use disorders. Eur Addict Res 1996, 2:36-47.
11. Roberts RE, Roberts CR, Xing Y. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: Evidence from an epidemiologic survey. Drug Alcohol Depend 2007, 88(Suppl 1):4-13.
12. Baumann A, Phongsavan P. Epidemiology of substance use in adolescence: prevalence, trends and policy implications. Drug Alcohol Depend 1999, 55:187-207. 10.1016/S0376-8716(99)00016-2, 10428361.
13. Couwenbergh C, van den Brink W, Zwart K, Vreugdenhil C, van Wijngaarden-Cremers P, van der Gaag RJ. Comorbid psychopathology in adolescents and young adults treated for substance use disorders: a review. Eur Child Adolesc Psychiatry 2006, 15:319-328. 10.1007/s00787-006-0535-6, 16648966.
14. Gordon SM, Tulak F, Troncale J. Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence. J Addict Dis 2004, 23:31-40. 10.1300/J069v23n04_03, 15339712.
15. Grilo CM, Becker DF, Fehon DC, Edell WS, McGlashan TH. Conduct Disorder, Substance Use Disorders and Coexisting Conduct and Substance Use Disorders in Adolescent Inpatients. Am J Psychiatry 1996, 153:914-920.
16. Hser YI, Grella CE, Collins C, Teruya C. Drug-use initiation and conduct disorder among adolescents in drug treatment. J Adolesc 2003, 26:331-345.
17. Molina BSG, Bukstein OG, Lynch KG. Attention-deficit/hyperactivity disorder and conduct disorder symptomatology in adolescents with alcohol use disorder. Psychol Addict Behav 2002, 16:161-164. 10.1037/0893-164X.16.2.161, 12079256.
18. Hayatbakhsh MR, Najman JM, Jamrozik K, Mamun AA, Alati R, Bor W. Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry 2007, 46:408-417. 10.1097/chi.0b013e31802dc54d, 17314727.
19. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005, 330:11. 10.1136/bmj.38267.664086.63, 539839, 15574485.
20. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005, 19:187-194. 10.1177/0269881105049040, 15871146.
21. Crowley TJ, Macdonald MJ, Whitmore EA, Mikulich SK. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend 1998, 50:27-37. 10.1016/S0376-8716(98)00003-9, 9589270.
22. Grella CE, Hser YI, Joshi V, Rounds-Bryant J. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 2001, 189:384-392. 10.1097/00005053-200106000-00006, 11434639.
23. Hannesdóttir H, Tyrfingsson T, Piha J. Psychosocial functioning and psychiatric comorbidity among substance-abusing Icelandic adolescents. Nord J Psychiatry 2001, 55:43-48. 10.1080/080394801750093742, 11827606.
24. Robbins MS, Kumar S, Walker-Barnes C, Feaster DJ, Briones E, Szapocznik J. Ethnic differences in comorbidity among abusing adolescents referred to outpatient therapy. J Am Acad Child Adolesc Psychiatry 2002, 41:394-401. 10.1097/00004583-200204000-00011, 11931595.
25. Tims FM, Dennis ML, Hamilton N. Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction 2002, 97:46-57. 10.1046/j.1360-0443.97.s01.7.x, 12460128.
26. Wise BK, Cuffe SP, Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treatment 2001, 21:161-165.
27. Rowe CL, Liddle HA, Greenbaum PE, Henderson CE. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J Subst Abuse Treatment 2004, 26:129-40.
28. Deas D, St Germaine K, Upadhyaya H. Psychopathology in substance abusing adolescents: gender comparisons. J Subst Abuse 2006, 11:45-51.
29. Hovens JGFM, Cantwell DP, Kiriakos R. Psychiatric Comorbidity in Hospitalized Adolescent Substance Abusers. J Am Acad Child Adolesc Psychiatry 1994, 33:476-483. 10.1097/00004583-199405000-00005, 8005900.
30. Jainchill N, De Leon G, Yagelka J. Ethnic Differences in Psychiatric Disorders among Adolescent Substance Abusers in Treatment. J Psychopathol Behav Assess 1997, 19:133-148.
31. Kelly TM, Cornelius JR, Clark DB. Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug Alcohol Depend 2004, 73:87-97. 10.1016/j.drugalcdep.2003.10.004, 14687963.
32. American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders 1994, Washington: American Psychiatric Association, 4, American Psychiatric Association (APA).
33. American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders 1987, Washington: American Psychiatric Association, 3, American Psychiatric Association (APA).
34. American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders 2000, Washington: American Psychiatric Association, 4, American Psychiatric Association (APA).
35. Wittchen HU, Lachner G, Wunderlich U, Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 1998, 33:568-578. 10.1007/s001270050095, 9803825.
36. Wittchen HU, Pfister H. DIA-X - Diagnostisches Expertensystem für Psychische Störungen 1997, Frankfurt: Harcourt Test Services.
37. World Health Organization Composite International Diagnostic Interview (CIDI) 1990, Genf: World Health Organization, World Health Organization.
38. Delmo C, Weiffenbach O, Gabriel M, Poustka F. Kiddie-SADS present and lifetime version (K-SADS-PL) 2000, Frankfurt: Johann Wolfgang Goethe-Universität Frankfurt.
39. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. Schedule for affective disorders and schizophrenia for school-aged children - present and lifetime (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997, 36:980-988. 10.1097/00004583-199707000-00021, 9204677.
40. Kaufman J, Birmaher B, Brent D, Rao U, Ryan N. Kiddie SADS - Present and Lifetime Version (K-SADS-PL) 1996, Pittsburgh: University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinics.
41. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991, 86:1119-1127. 10.1111/j.1360-0443.1991.tb01879.x, 1932883.
42. Franke G. SCL-90-R -- Die Symptom-Checkliste von L.R. Derogatis 2002, Göttingen: Beltz Test Verlag.
43. Derogatis LR. The Symptom Checklist-90-revised 1992, Minneapolis: NCS Assessments.
44. Friedmann AS, Utada A. A method for diagnosing and planning the treatment of adolescent drug abusers (the Adolescent Drug Abuse Diagnosis [ADAD] instrument). J Drug Educ 1989, 19:285-312.
45. Essau CA, Karpinski NA, Petermann F, Conradt J. Störungen durch Substanzkonsum bei Jugendlichen. Kindheit und Entwicklung 1998, 7:199-207.
46. Edelbrock C, Costello AJ, Dulcan MK, Conover NC, Kalas R. Parent-child agreement on child psychiatric symptoms assessed via structured interview. J Child Psychol Psychiatry 1986, 27:181-190.